Sort   by:  
 Page size 
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
TranscriptomicsMiRNA expression profiling or ERCC1 deficient and control mouse lineage negative bone marrow cells
MiRNA expression differences induced by ERCC1 deficiency.
ORGANISM(S): Mus musculus 
2015-04-09 | E-MTAB-3298 | biostudies-arrayexpress
TranscriptomicsMiRNA expression profiling or ERCC1 deficient and control mouse lineage negative, ScaI positive, Kit positive (LSK) bone marrow cells
MiRNA expression differences induced by ERCC1 deficiency.
ORGANISM(S): Mus musculus 
2015-04-09 | E-MTAB-3310 | biostudies-arrayexpress
TranscriptomicsGene expression profiling or ERCC1 deficient and control mouse lineage negative bone marrow cells
Transcriptome differences induced by ERCC1 deficiency.
ORGANISM(S): Mus musculus 
2015-04-09 | E-MTAB-3297 | biostudies-arrayexpress
UnknownSafety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
Not available
S-EPMC7613326 | biostudies-literature
UnknownSafety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
Not available
S-EPMC7613317 | biostudies-literature
UnknownLiraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288 | biostudies-literature
UnknownStoma-free Survival After Rectal Cancer Resection With Anastomotic Leakage: Development and Validation of a Prediction Model in a Large International Cohort.
Not available
S-EPMC10549897 | biostudies-literature
UnknownAVERT2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff.
Not available
S-EPMC4676118 | biostudies-literature
UnknownExploring threats to generalisability in a large international rehabilitation trial (AVERT).
Not available
S-EPMC4550737 | biostudies-literature
Sort   by:  
 Page size